Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/10181
Title: Cholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid carcinoma: case report and review
Authors: Tramontin, Mariana Yoshii
Faria, Paulo Antonio Silvestre de
Nascimento, Cristina Moreira do
Barbosa, Cibele de Aquino
Barros, Maria de Fátima Rei Pereira
Barros, Aniela Rodrigues Gomes de
Carvalho, Rafaela Cardoso de
Castro Neto, Antônio Kneipp Pitta de
Andrade, Fernanda Accioly de
Vaisman, Fernanda
Bulzico, Daniel Alves
Mello, Rossana Corbo Ramalho de
Keywords: Pâncreas
Pancreas
Câncer Papilífero da Tireoide
Thyroid Cancer Papillary
Colestase
Cholestasis
Issue Date: 2020
Publisher: Arch Endocrinol Metab.
Citation: TRAMONTIN, Mariana Yoshii et al. Cholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid carcinoma: case report and review. Arch Endocrinol Metab., v. 64, n. 2, p. 1-6, 2020.
Abstract: Most papillary thyroid carcinomas (PTC) harbor excellent prognosis. Although rare, distant metastases normally occur in lungs and/or bones. Here we describe a rare case of pancreatic metastasis presenting with rapid onset cholestatic syndrome. A literature review was also performed. A 73-year old man with a high risk PTC was submitted to total thyroidectomy (TT) followed by radioiodine therapy. After initial therapy, he persisted with progressive rising serum thyroglobulin levels but with no evidence of structural disease. Recently, the patient presented with a rapid onset and progressive cholestatic syndrome. A 4 cm lesion in pancreas was identified, with echoendoscopy fine-needle aspiration biopsy (FNAB) confirming a pancreatic metastasis from PTC. The patient was submitted to a successful pancreaticoduodenectomy. Pancreatic metastases of PTC are rare and few long-term follow-up data are available to guide management. Fourteen cases were former reported, mean age was 65.7 years-old with mean time between PTC and pancreatic metastasis diagnosis of 7.9 years. Nine of them had another distant metastasis, nine were diagnosed by FNAB and just two received sorafenib.
Description: p. 1-6.: tab. p&b,
URI: http://sr-vmlxaph03:8080/jspui/handle/123456789/10181
ISSN: 2359-4292
Appears in Collections:Artigos de Periódicos da área de Oncologia Clínica



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.